Kairos Pharma, Ltd. KAPA
AMEX · United States · Health Technology
$1.56-0.08 (-4.88%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.56 | -0.56 | 0.0% | $0 | — | -0.8%$2.54→$2.52 |
| Q1 2026 | 2026-05-13 | -0.56 | -0.49 | -14.3% | — | — | +1.4%$3.39→$3.44 |
| Q4 2025 | 2026-03-31 | -0.49 | 0.21 | -333.3% | — | — | +5.3%$3.85→$4.05 |
| Q3 2025 | 2025-11-14 | -0.49 | -0.70 | +30.0% | — | — | -1.9%$5.54→$5.43 |
| Q4 2024 | 2025-04-15 | -0.22 | -0.14 | -57.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.